Wave Life Sciences (WVE) Common Equity: 2015-2025
Historic Common Equity for Wave Life Sciences (WVE) over the last 10 years, with Sep 2025 value amounting to $124.5 million.
- Wave Life Sciences' Common Equity fell 12.07% to $124.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $124.5 million, marking a year-over-year decrease of 12.07%. This contributed to the annual value of $209.5 million for FY2024, which is 428.68% up from last year.
- As of Q3 2025, Wave Life Sciences' Common Equity stood at $124.5 million, which was down 10.57% from $139.3 million recorded in Q2 2025.
- Wave Life Sciences' 5-year Common Equity high stood at $209.5 million for Q4 2024, and its period low was -$51.7 million during Q2 2023.
- Over the past 3 years, Wave Life Sciences' median Common Equity value was $39.6 million (recorded in 2023), while the average stood at $65.6 million.
- Per our database at Business Quant, Wave Life Sciences' Common Equity tumbled by 65,398.11% in 2023 and then skyrocketed by 4,105.35% in 2025.
- Quarterly analysis of 5 years shows Wave Life Sciences' Common Equity stood at $32.5 million in 2021, then tumbled by 238.75% to -$45.1 million in 2022, then surged by 187.89% to $39.6 million in 2023, then skyrocketed by 428.68% to $209.5 million in 2024, then decreased by 12.07% to $124.5 million in 2025.
- Its last three reported values are $124.5 million in Q3 2025, $139.3 million for Q2 2025, and $171.8 million during Q1 2025.